packageOrelabrutinib

orelabrutinib

Extends from Pharmacolibrary.Interfaces.PartialSubstance (Identity and physicochemical constants of one drug (Drugs.Substances)).

Information

Orelabrutinib is a Bruton's tyrosine kinase inhibitor being studied as an anticancer treatment. It remains investigational and is not an approved medicine in the European Union.

Summary written by glm-5.3-flash from Wikidata Q126122244 and the WHO ATC classification; not checked by a person.

name:orelabrutinib
ATC codes:L01EL04
DrugBank:DB16272
PubChem CID:91667513
Wikidata:Q126122244
formula:C26H25N3O3
molar mass:427.504 g/mol (PubChem CID 91667513)
logP:3.6 (Drugs.Common 25.09, not verified)

Parameters

TypeNameDefaultDescription
Stringname (from PartialSubstance)""INN / common name
String[:]atcCodes (from PartialSubstance)fill("", 0)all WHO ATC codes of the drug
StringdrugbankId (from PartialSubstance)""e.g. DB00758
StringpubchemCid (from PartialSubstance)""PubChem compound id
StringchebiId (from PartialSubstance)""ChEBI id (number)
StringwikidataId (from PartialSubstance)""e.g. Q410238
Stringformula (from PartialSubstance)""molecular formula
Modelica.Units.SI.MolarMassM (from PartialSubstance)0molar mass; 0 = unknown
ReallogP (from PartialSubstance)Modelica.Constants.infoctanol-water partition coefficient (log10); inf = unknown